Ok Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 30, 2021 at 05:18 pm EDT
Share
OK Biotech Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 1,484.413 million compared to TWD 1,241.252 million a year ago. Operating income was TWD 126.100 million compared to TWD 110.997 million a year ago. Net income was TWD 129.728 million compared to TWD 125.760 million a year ago. Basic earnings per share was TWD 1.56 compared to TWD 1.71 a year ago. Diluted earnings per share was TWD 1.45 compared to TWD 1.62 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 